Ziv-aflibercept Efficacy in Better Regulating AMD

NCT03423823 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Wet Macular Degeneration
Wet Age-related Macular Degeneration

Interventions

DRUG: Ziv-Aflibercept 25 MG/ML [Zaltrap]
DRUG: Ranibizumab

Sponsor

Kapil Kapoor